pal-ghk-cu AHK-Cu (200mg) Palmitoyl Tripeptide GHK-Cu | Copper Peptide Face
Description
the onset of cirrhotic decompensation or HCC) to guide the clinical decisions for liver transplantation
Discovery and development of exenatide: The first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
PLoS ONE 9, e97378 (2014)
HGF-HM201) with an EC of 15.9 ng/mL determined by ELISA (QC test)
PMID: 35125818
